ArticleNPJ Parkinson's disease2025
Neural signatures of turn-induced freezing of gait in Parkinson's disease: insights from phase-specific cortico-subthalamic dynamics.
Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Freezing of gait (FOG), particularly during turning, is common in Parkinson's disease (PD), but its phase-specific neural mechanisms remain unclear. This study investigated cortico-subthalamic dynamics underlying turning-induced FOG and their modulation by dopaminergic medication. Local field potentials from primary motor cortex (M1), premotor cortex (PMC), bilateral subthalamic nucleus (STN), and kinematic data were recorded from 19 PD patients during timed up-and-go tasks in medication-off and medication-on states. Turns were segmented into four phases: TurnPre, TurnStart, TurnEnd, and TurnPost. During freezing episodes, alpha power in M1 and PMC significantly decreased in early turning phases. Enhanced PMC-STN coherence appeared during TurnPre in normal turning and TurnStart in freezing turning, with TurnPre alpha suppression and coherence predicting freezing duration. Medication normalized these abnormal oscillations and improved turning. These findings reveal phase-specific cortico-subthalamic disruptions in FOG and suggest novel electrophysiological biomarkers for intervention. Trial Registration: ChiCTR1900026601, registered October 15, 2019.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.